Results 141 to 150 of about 1,844 (180)

Efficacy and safety of myosin inhibitors for symptomatic hypertrophic cardiomyopathy: systematic review and meta-analysis. [PDF]

Arch Med Sci Atheroscler Dis
Hazique M, Lohana S, Kafle S, Bhinder J, Patel KN, Basit J, Bahar AR, Kvapil J, Alraies MC.   +8 more
europepmc   +1 more source

Use of Advanced Transthoracic Echocardiography in Special Cardiac Conditions [PDF]

Nagy Viktória
core  

Coexistence of Hypertrophic Cardiomyopathy and Arterial Hypertension: Current Insights and Future Directions. [PDF]

Diseases
Katsi V, Papadomarkaki K, Manousiadis K, Triantafyllou E, Fragoulis C, Tsioufis K.   +5 more
europepmc   +1 more source

Chemical myectomy with mavacamten in patients with obstructive hypertrophic cardiomyopathy with prior septal reduction therapy: A single-center experience. [PDF]

JTCVS Open
Hundal P, Abood Z, Sanders H, Misicka A, Galazka P, Jahangir A, Jan MF, Tajik AJ.   +7 more
europepmc   +1 more source

Early Detection of Treatment Response to Mavacamten in Hypertrophic Obstructive Cardiomyopathy With Severe Mitral Regurgitation Using Magnetocardiography. [PDF]

Clin Case Rep
Suwalski P, Satilmis G, Reinthaler M, Landmesser U, Heidecker B.   +4 more
europepmc   +1 more source

Letter to the editor concerning: Catastrophic apical ballooning in obstructive hypertrophic cardiomyopathy patient treated with mavacamten. [PDF]

Eur Heart J Case Rep
Sherrid MV, Kim B, Massera D.
europepmc   +1 more source

Concurrent Use of Tafamidis and Mavacamten for Transthyretin Cardiac Amyloidosis With Severe Outflow Tract Obstruction. [PDF]

JACC Case Rep
Kassamali AA, Vaishnav J, Czarny MJ, Blake V, Gupta V, Johnson J, Zimmerman SL, Madrazo JA, Carrick RT.   +8 more
europepmc   +1 more source

Effects of Mavacamten on Cardiac Magnetic Resonance Features in Chinese Patients With Obstructive Hypertrophic Cardiomyopathy. [PDF]

JACC Asia
Tian Z, Li L, Li X, Zhang Q, Peng D, Ma W, Yang P, Wang F, Cheng X, Fu Y, Sun J, Wang J, Zhang S.   +12 more
europepmc   +1 more source

Cardiac myosin inhibitors in hypertrophic cardiomyopathy. [PDF]

J Cardiovasc Imaging
Lim J, Kim HK.
europepmc   +1 more source